ARGUS® SC/ST
Salmonella Choleraesuis Vaccine
Product Description
An aid in the prevention of pneumonia, diarrhea, septicemia and mortality caused by Salmonella choleraesuis and as an aid in control of disease and shedding of Salmonella typhimurium. For mass application of pigs 3 weeks of age or older through the drinking water. Dual-strain protection and safety. Freeze-dried avirulent live culture.
Indications
For healthy swine 3 weeks of age or older; used as an aid in the prevention of pneumonia, diarrhea, septicemia and mortality caused by S. choleraesuis and as an aid in the control of disease and shedding caused by S. typhimurium.
Advantages
- Avirulent live Salmonella choleraesuis
- Proven protection against BOTH Salmonella choleraesuis and Salmonella typhimurium1
- Patented gene deletions remain stable after in vitro and in vivo backpassages1
- Vaccine cannot revert to virulence1
- Effectively controls pneumonia, diarrhea, septicemia and mortality caused by Salmonella choleraesuis1
- Effectively controls disease and shedding of Salmonella typhimurium1
- Recommended for use in pigs 3 weeks of age and older
- Mass oral vaccination through drinking water saves labor1
Downloads
For additional information, please see the product label.
References
- Data on file, Merck Animal Health.
Go To United States
Algeria
Argentina
Australia
Austria
Bahrain
Belgium (Dutch)
Brazil
Canada (English)
Chile
Colombia
Croatia
Czech Republic
Denmark
Ecuador
Egypt
Finland
France
Germany
Greece
Hungary
India
Indonesia
Iraq
Ireland
Israel
Italy
Japan
Jordan
Kuwait
Lebanon
Malaysia
Mexico
Morocco
Netherlands
New Zealand
Norway
Oman
Panama
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russian Federation
Saudi Arabia
South Africa
South Korea
Spain
Sweden
Switzerland (French)
Taiwan
Thailand
Tunisia
Turkey
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Yemen
Global